Ignite Creation Date:
2025-12-24 @ 7:45 PM
Ignite Modification Date:
2026-05-07 @ 4:26 PM
Study NCT ID:
NCT06401603
Status:
RECRUITING
Last Update Posted:
2025-09-11
First Post:
2024-05-02
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase I Study of Decitabine, Lisaftoclax, and Olverembatinib in Patients With Advanced Chronic Myeloid Leukemia and Philadelphia Chromosome-Positive Acute Myeloid Leukemia
Sponsor:
Organization: